Dr. Hynda K. Kleinman
Biography & Research Background
Hynda K. Kleinman, Ph.D., is affiliated with George Washington University (Department of Biochemistry and Molecular Biology) and formerly with the National Institutes of Health (NIDCR). Dr. Kleinman conducted foundational research isolating the biological activities of Tβ4 to specific peptide sequences. She co-authored key studies showing that the actin-binding motif LKKTETQ (the sequence of TB-500) is essential and sufficient for angiogenesis and endothelial cell migration, and confirmed this fragment's ability to accelerate dermal wound healing. Hynda K. Kleinman is being referenced as one of the leading scientists involved in the research and development of TB-500 and Thymosin Beta-4. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Hynda K. Kleinman is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Hynda K. Kleinman is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.